Literature DB >> 3100946

Mutagens formed from butylated hydroxyanisole treated with nitrite under acidic conditions.

M Mizuno, A Ohara, G Danno, K Kanazawa, M Natake.   

Abstract

The reaction products from butylated hydroxyanisole treated with nitrite under acidic conditions were investigated for mutagenic activity in Salmonella typhimurium his reversion assay and for DNA-damaging activity using H17 Rec+ (wild) and M45 Rec- (recombinationless) of Bacillus subtilis. The chloroform extract of the reaction mixture showed 9 spots on thin-layer chromatography (TLC). Compounds from 2 spots on the TLC had high mutagenic activity in TA100 without S9 mix, with DNA-damaging activity. The 2 mutagens were then crystallized from the reaction mixture and identified to be 2-tert.-butyl-p-quinone (t-BQ) and the dimer of t-BQ; 3,3'-di-tert.-butyl-biphenyldiquinone-(2,5,2',5') (BBDQ), from their instrumental analysis. The mutagenic activities of t-BQ and BBDQ were determined by Ames test, and the induced mutation frequencies were about 1.9 X 10(-4) (t-BQ) and 8.3 X 10(-5) (BBDQ).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100946     DOI: 10.1016/0027-5107(87)90048-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Renal carcinogenicity of concurrently administered fish meal and sodium nitrite in F344 rats.

Authors:  F Furukawa; A Nishikawa; H Ishiwata; M Takahashi; Y Hayashi; M Hirose
Journal:  Jpn J Cancer Res       Date:  2000-02

2.  The reaction of butylated hydroxyanisole and its metabolites with some arylamines: investigations of product mutagenicity.

Authors:  W H Kalus; R Münzner; W G Filby
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

3.  Effects of combined treatment with phenolic compounds and sodium nitrite on two-stage carcinogenesis and cell proliferation in the rat stomach.

Authors:  M Kawabe; K Takaba; Y Yoshida; M Hirose
Journal:  Jpn J Cancer Res       Date:  1994-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.